GeneSys Biotech is a technology-driven reagent manufacturer specialising in the development and production of high-quality enzymes and reagents. Founded in 1987, the company has a long-standing reputation for expertise, reliability, and agility within the life sciences sector.
Since 1987, GeneSys Biotech has developed and manufactured high-performance molecular biology enzymes and reagents, supporting accurate, reliable, and robust molecular diagnostics.
During the COVID-19 pandemic, GeneSys Biotech played a key role in supporting mass testing, providing reagents for one of the three major NHS testing streams.
We develop and manufacture high-performance enzymes, reagents, and custom assay solutions, supporting assay development, OEM partnerships, and scalable manufacturing.
Quality, consistency, and reliability are central to our approach. Through ISO-aligned manufacturing and quality systems, we deliver reproducible performance and dependable results across molecular diagnostic and research workflows.
In 2025, GeneSys Biotech became an Employee Ownership Trust (EOT), reinforcing our commitment to the people who drive our success. GeneSys Biotech continues to grow as a self-sustaining, innovation-focused company, working closely with partners worldwide to advance molecular diagnostics and biotechnology.
Duncan Clark starts GeneSys in a home laboratory after discovering novel restriction enzymes, which are still on the market today
GeneSys takes commercial premises in Reading – a stark contrast to our current 15,000 sq/ft state of the art laboratory!
As demand increases, GeneSys moves to a lab in Farnborough and take on first employee
GeneSys move into 15,000 sq/ft purpose-built laboratories in Camberley, where we are still based
